C13 Malignant neoplasm of hypopharynx - analogs
| Description «C13 Malignant neoplasm of hypopharynx» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 30% Compare C32 Malignant neoplasm of larynx
- 30% Compare C13.9 Malignant neoplasm, hypopharynx, unspecified
- 30% Compare C13.1 Malignant neoplasm, aryepiglottic fold, hypopharyngeal aspect
- 30% Compare C13.8 Malignant neoplasm, overlapping lesion of hypopharynx
- 30% Compare C14.1 Malignant neoplasm, laryngopharynx
- 23% Compare C13.2 Malignant neoplasm, posterior wall of hypopharynx
- 20% Compare C10 Malignant neoplasm of oropharynx
- 20% Compare C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
- 15% Compare C11.8 Malignant neoplasm, overlapping lesion of nasopharynx
- 15% Compare C11.9 Malignant neoplasm, nasopharynx, unspecified
- 15% Compare C11.2 Malignant neoplasm, lateral wall of nasopharynx
- 15% Compare C11.1 Malignant neoplasm, posterior wall of nasopharynx
- 15% Compare C11.3 Malignant neoplasm, anterior wall of nasopharynx
- 15% Compare C11.0 Malignant neoplasm, superior wall of nasopharynx
- 10% Compare C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
- 10% Compare D13.4 Benign neoplasm, liver
- 10% Compare C50.4 Malignant neoplasm, upper-outer quadrant of breast
- 10% Compare C34.1 Malignant neoplasm, upper lobe, bronchus or lung
- 10% Compare C50.8 Malignant neoplasm, overlapping lesion of breast
- 10% Compare C34.9 Malignant neoplasm, bronchus or lung, unspecified
- 10% Compare C92.7 Other myeloid leukaemia
- 10% Compare C71.8 Malignant neoplasm, overlapping lesion of brain
- 10% Compare C44.5 Malignant neoplasm, skin of trunk
- 10% Compare E88.3 Tumour lysis syndrome
- 10% Compare C18.3 Malignant neoplasm, hepatic flexure
- 10% Compare C50 Malignant neoplasm of breast
- 10% Compare C92 Myeloid leukaemia
- 10% Compare D29.0 Benign neoplasm, penis
- 10% Compare C91.9 Lymphoid leukaemia, unspecified
- 10% Compare C22.9 Malignant neoplasm, liver, unspecified
- 10% Compare C93 Monocytic leukaemia
- 10% Compare C51.9 Malignant neoplasm, vulva, unspecified
- 10% Compare C50.9 Malignant neoplasm, breast, unspecified
- 10% Compare C91 Lymphoid leukaemia
- 10% Compare C25.1 Malignant neoplasm, body of pancreas
- 10% Compare C49.3 Malignant neoplasm, connective and soft tissue of thorax
- 10% Compare C15.5 Malignant neoplasm, lower third of oesophagus
- 10% Compare C40 Malignant neoplasm of bone and articular cartilage of limbs
- 10% Compare C71 Malignant neoplasm of brain
- 10% Compare C41.4 Malignant neoplasm, pelvic bones, sacrum and coccyx
- 10% Compare C50.2 Malignant neoplasm, upper-inner quadrant of breast
- 10% Compare C50.1 Malignant neoplasm, central portion of breast
- 10% Compare C76-C80 Malignant neoplasms of inaccurately designated, secondary and unspecified localizations
- 10% Compare C77 Secondary and unspecified malignant neoplasm of lymph nodes
- 10% Compare C38.3 Malignant neoplasm, mediastinum, part unspecified
- 10% Compare C79.3 Secondary malignant neoplasm of brain and cerebral meninges
- 10% Compare C50.5 Malignant neoplasm, lower-outer quadrant of breast
- 10% Compare C41.0 Malignant neoplasm, bones of skull and face
- 10% Compare C49.4 Malignant neoplasm, connective and soft tissue of abdomen
- 10% Compare C40-C41 Malignant neoplasms of bones and articular cartilage
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnosis.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.